TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy

MLA

Pirovano, Giacomo, et al. “TOPK Modulates Tumour-Specific Radiosensitivity and Correlates with Recurrence after Prostate Radiotherapy.” British Journal of Cancer, vol. 117, no. 4, July 2017, pp. 503–12. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....c416fb7bfba2e575c749cd24898b29b3&authtype=sso&custid=ns315887.

APA

Pirovano, G., Ashton, T. M., Herbert, K. J., Bryant, R. J., Verrill, C. L., Cerundolo, L., Buffa, F. M., Prevo, R., Harrap, I., Ryan, A. J., Macaulay, V., McKenna, W. G., & Higgins, G. S. (2017). TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy. British Journal of Cancer, 117(4), 503–512.

Chicago

Pirovano, Giacomo, Thomas M. Ashton, Katharine J. Herbert, Richard J. Bryant, Clare L. Verrill, Lucia Cerundolo, Francesca M. Buffa, et al. 2017. “TOPK Modulates Tumour-Specific Radiosensitivity and Correlates with Recurrence after Prostate Radiotherapy.” British Journal of Cancer 117 (4): 503–12. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....c416fb7bfba2e575c749cd24898b29b3&authtype=sso&custid=ns315887.